Anamorelin Hydrochloride Tablets 50mg (Adlumiz® / エドルミズ錠50mg)

JPY ¥31,300

Japanese ghrelin receptor agonist (Anamorelin Hydrochloride 50mg). Oral tablet for treatment of cancer cachexia in non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Ono Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥28,796
10 - 19 12% JPY ¥27,544
20 + 18% JPY ¥25,666
SKU: ADL-50-TAB Category:

Description

Product Overview / 商品概要

Adlumiz Tablets 50mg (エドルミズ錠50mg)
Generic: Anamorelin Hydrochloride / アナモレリン塩酸塩
Therapeutic Category: Ghrelin receptor agonist / グレリン様作用薬
Manufactured by: Ono Pharmaceutical Co., Ltd. / 小野薬品工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Anamorelin Hydrochloride 50mg per tablet / 1錠中 アナモレリン塩酸塩50mg
Additives: Microcrystalline cellulose, Croscarmellose sodium, Light anhydrous silicic acid, Magnesium stearate, Hypromellose, Titanium oxide, Talc, Yellow ferric oxide / 結晶セルロース、クロスカルメロースナトリウム、軽質無水ケイ酸、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、タルク、黄色三二酸化鉄
Appearance: Film-coated tablet, light yellow, major axis approx. 14.1mm, minor axis approx. 6.6mm, thickness approx. 5.2mm, weight approx. 364mg
外観: フィルムコーティング錠、薄い黄色、長径 約14.1mm、短径 約6.6mm、厚さ 約5.2mm、質量 約364mg

Indications / 効能効果

EN: Cancer cachexia in the following malignancies: non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer
JA: 下記の悪性腫瘍におけるがん悪液質
非小細胞肺癌、胃癌、膵癌、大腸癌

Dosage and Administration / 用法用量

EN: The usual adult dose is 100mg of anamorelin hydrochloride administered orally once daily on an empty stomach.
JA: 通常、成人にはアナモレリン塩酸塩として100mgを1日1回、空腹時に経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; patients with congestive heart failure; patients with myocardial infarction or angina pectoris; patients with severe conduction system disorders (e.g., complete atrioventricular block); patients receiving clarithromycin, itraconazole, voriconazole, ritonavir-containing products, cobicistat-containing products, ensitrelvir fumarate, or ceritinib; patients with moderate or severe hepatic impairment (Child-Pugh Class B or C); patients with difficulty in oral food intake due to gastrointestinal obstruction or other organic gastrointestinal abnormalities
JA: 本剤の成分に対し過敏症の既往歴のある患者、うっ血性心不全のある患者、心筋梗塞又は狭心症のある患者、高度の刺激伝導系障害(完全房室ブロック等)のある患者、クラリスロマイシン・イトラコナゾール・ボリコナゾール・リトナビル含有製剤・コビシスタット含有製剤・エンシトレルビル フマル酸・セリチニブを投与中の患者、中等度以上の肝機能障害(Child-Pugh分類B及びC)のある患者、消化管閉塞等による食事の経口摂取が困難な患者

Regulatory Information / 規制情報

Approval No.: 30300AMX00003000
Sales Started: April 2021 / 2021年4月
Classification Code: 873999
Storage: Store at room temperature / 室温保存
Shelf Life: 4 years / 4年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Anamorelin Hydrochloride Tablets 50mg (Adlumiz® / エドルミズ錠50mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Anamorelin Hydrochloride Tablets 50mg (Adlumiz®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.